May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…

The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
In this Fireside Chat, Natalie Yeadon sat down with Anand Iyer, Chief Strategy Officer at Welldoc and discussed a myriad of different topics, including AI and MR in healthcare and…
In the latest episode of Impetus Digital’s Fireside Chat, I sit down with an all-star panel of industry leaders who are also members of TECHNATION Health. I had the pleasure…
Learn how our client used Impetus Digital’s virtual tools and services to develop and execute a national educational webinar on telehealth.
In the latest episode of Impetus Digital’s Fireside Chat, we dive into the concept of merging art and science with Ariel Garten, Founder & Chief Evangelism Officer at Muse. Ariel…
In this session, we discussed the processes involved in systems innovation and reviewed a few examples. We examined the transformational changes that can evolve over time when we go beyond…
Natalie Yeadon shares her expertise on how you can make the most out of your asynchronous virtual meetings and ask effective questions virtually.
Ryan Wiley, President of Shift Health, discusses healthcare’s journey towards digitalization and the ramifications COVID-19 has had in many of these areas. We also talk about Ryan’s shift from academia to consulting…
Tom Hsu, VP of Specialty Medicine at Bayer Canada,  talks about how he got to where he is today and his experience working for Bayer in China, and how that compares to…
Ryan Zarychanski, Paul Komenda, and Marshall Pitz from MindSet, discuss a whole range of thought-provoking topics, including the barriers to and benefits of clinical data integration for the healthcare system, clinical trials, providers,…
Stephany Lapierre, Founder and CEO of Tealbook sits down with us in this Fireside Chat. Stephany is a highly coveted supply chain thought-leader, and one of the most influential minds in…
